44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Nephrology unit, Internal Medicine Department, School of Medicine, Cairo University, Egypt


  • Review   
    Time to stop using immunosuppressive agents in chronic glomerulonephritis
    Author(s): Usama AA Sharaf El Din*, Mona M Salem and Dina O Abdulazim

    Chronic glomerulonephritis is the third most important cause of end stage renal disease worldwide. Most of the patients suffering different types of glomerulonephritis are prescribed different immunosuppressive agents aiming at complete or partial remission in order to stop or muffle the progression of chronic kidney disease. Although the initial injury in case of glomerulonephritis is the glomerulus, the best predictor of renal survival is the amount of tubulointerstitial fibrosis. Recent trials have proved the efficacy of the anti-diabetic sodium glucose cotransporters-2 inhibitors in non-diabetic chronic kidney disease to significantly decrease the renal end points. Chronic glomerulonephritis represented a considerable bulk of nondiabetic cases recruited in these studies. This success should stimulate clinical Nephrologists to consider these agents in the newly diagnosed cases suff.. Read More»
    DOI: 10.37532/puljmbr.2023.6(1).19-23


Recommended Conferences

14th World Congress on Cell & Tissue Science

Rome, Italy
Journal of Microbiology and Biotechnology Reports peer review process verified at publons